Skip to content

A Comparison of the Ambu AuraGain Versus LMA Supreme in Children

A Randomized Comparison of the Ambu AuraGain™ and LMA Supreme™ in Infants and Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02380768
Enrollment
100
Registered
2015-03-05
Start date
2015-03-31
Completion date
2015-06-30
Last updated
2015-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supraglottic Airway

Keywords

Supraglottic airway, Laryngeal mask airway, Children

Brief summary

The purpose of this study is to determine whether there is a clinically relevant difference in airway leak pressures between the Ambu AuraGain and the Laryngeal Mask Airway (LMA) Supreme.

Detailed description

The goal of this prospective randomized study is to compare whether there is a clinically relevant difference in airway leak pressures between the Ambu AuraGain (sizes 1.5 and 2) and the Laryngeal Mask Airway (LMA) Supreme. Parameters of clinical relevance such as insertion success rates, fiberoptic view of the glottic opening, ease and speed of gastric tube placement, airway stability, and peri-operative complications will also be assessed.

Interventions

DEVICEAmbu AuraGain (size 1.5 or size 2.0)

The device will be inserted and timed. A leak pressure test will be performed after successful insertion and after 10 minutes. The larynx will be visualized by placing a fiberoptic bronchoscope through the device. A gastric tube will be inserted through the device and timed.

DEVICELMA Supreme (size 1.5 or size 2.0)

The device will be inserted and timed. A leak pressure test will be performed after successful insertion and after 10 minutes. The larynx will be visualized by placing a fiberoptic bronchoscope through the device. A gastric tube will be inserted through the device and timed.

Sponsors

Ann & Robert H Lurie Children's Hospital of Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
3 Months to 6 Years
Healthy volunteers
Yes

Inclusion criteria

* Scheduled for surgery utilizing a supraglottic airway device * ASA (American Society of Anesthesiologists) I-III classification * Weighing between 5 - 20 kilograms

Exclusion criteria

* Active respiratory infection * History of difficult mask ventilation * Diagnosis of congenital syndrome with difficult airway management * Active gastrointestinal reflux * Coagulopathy * Significant Pulmonary disease * Emergent surgery

Design outcomes

Primary

MeasureTime frameDescription
Oropharyngeal (airway) leak pressure - InitialAssessed intraoperatively at the time of confirmed device placementThe airway pressure at which an airway leak is observed after successful placement of the supraglottic airway
Oropharyngeal (airway) leak pressure - 10 MinutesAssessed intraoperatively, 10 minutes after the initial confirmed placement of the deviceThe airway pressure at which an airway leak is observed 10 minutes after successful placement of the supraglottic airway

Secondary

MeasureTime frameDescription
Fiberoptic Grade of Laryngeal View through Supraglottic AirwayAssessed intraoperatively at the time of confirmed device placementFiberoptic Grade of Laryngeal View through either device will be graded using a previously published grading system
Gastric Tube Insertion Ease of PlacementAssessed intraoperatively at the time of confirmed gastric tube placementThe ease of placement, based on a 1-4 scale, will be recorded following placement and confirmation of the gastric tube.
Gastric Tube Insertion TimeAssessed intraoperatively at the time of confirmed gastric tube placementThe elapsed time from beginning insertion of the gastric tube to confirmation, will be recorded. Confirmation of gastric tube placement will be determined by injection of air with auscultation (listening for sounds) over the stomach with a stethoscope.
Time for Successful Placement of the Supraglottic AirwayAssessed intraoperatively at the time of confirmed device placementTime for successful placement of supraglottic device will be recorded
Postoperative ComplicationsParticipants will be followed for the duration of hospital stay. Outcome measure will be assessed postoperatively in recovery unit.Patient will be evaluated for sore throat, cough, dysphonia, stridor, or other airway related complications during the post-operative period.
Intraoperative ComplicationsAssessed intraoperativelyComplications such as reflex activation of the airway (coughing, breath holding, laryngospasm, bronchospasm), oxygen desaturation will be recorded, if they occur.
Gastric Tube Insertion AttemptsAssessed intraoperatively at the time of confirmed gastric tube placementNumber of insertion attempts of the gastric tube through the SGA will be recorded. Confirmation of gastric tube placement will be determined by injection of air with auscultation (listening for sounds) over the stomach with a stethoscope.
Number of attempts to placement of Supraglottic AirwayAssessed intraoperatively at the time of confirmed device placementNumber of attempts and insertion techniques will be recorded (maximum of 3 attempts)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026